Showing results (11-20 of 106) with videos related to
Sort By:
Pageof 11
European Journal of Endocrinology|October 21, 2016
MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trialsMarius N Stan, Mario SalviEuropean Thyroid Journal|July 7, 2025
The evolving therapeutic landscape of Graves' disease in adults: present and futureMarius N Stan, Chrysoula DosiouMayo Clinic Proceedings|March 30, 2019
Thyrotoxicosis: Diagnosis and ManagementAnu Sharma, Marius N StanThe Journal of Clinical Endocrinology and Metabolism|April 18, 2023
The Adverse Effects Profile of TeprotumumabMarius N Stan, Christine C KriegerThyroid : Official Journal of the American Thyroid Association|June 29, 2010
Risk factors for development or deterioration of Graves' ophthalmopathyMarius N Stan, Rebecca S BahnEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 20, 2008
Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancerRachel P Espiritu, Marius N StanThe Journal of Clinical Endocrinology and Metabolism|November 8, 2022
Measuring Health-Related Quality of Life in Thyroid Eye DiseaseAnu Sharma, Marius N Stan, Dan B RootmanThyroid : Official Journal of the American Thyroid Association|July 23, 2015
Early Hypoparathyroidism Reversibility with Treatment of Riedel's ThyroiditisMarius N Stan, Elizabeth G Haglind, Matthew T DrakeThe Medical Clinics of North America|March 27, 2012
The evaluation and treatment of graves ophthalmopathyMarius N Stan, James A Garrity, Rebecca S BahnThe Journal of Clinical Endocrinology and Metabolism|May 16, 2024
PAPP-A as a Potential Target in Thyroid Eye DiseaseCheryl A Conover, Laurie K Bale, Marius N StanPageof 11